Patologías múltiples y demencia en mayores de 90 años

1. Corrada MM, Brookmeyer R, Berlau D, Paganini-Hill A, Kawas CH. Prevalence of dementia after age 90: results from The 901 Study. Neurology 2008;71:337–343.

2. Corrada MM, Brookmeyer R, Paganini-Hill A, Berlau D, Kawas CH. Dementia incidence continues to increase with age in the oldest-old: The 901 Study. Ann Neurol 2010; 67:114–121.

3. Jellinger KA, Attems J. Prevalence of dementia disorders in the oldest-old: an autopsy study. Acta Neuropathol 2010; 119:421–433.

4. Savva GM, Wharton SB, Ince PG, Forster G, Matthews FE, Brayne C. Age, neuropathology, and dementia. N Engl J Med 2009;360:2302–2309.

5. James BD, Bennett DA, Boyle PA, Leurgans S, Schneider JA. Dementia from Alzheimer disease and mixed pathologies in the oldest old. JAMA 2012;307:1798–1800.

6. White L, Small BJ, Petrovitch H, et al. Recent clinicalpathologic research on the causes of dementia in late life: update from the Honolulu-Asia Aging Study. J Geriatr Psychiatry Neurol 2005;18:224–227.

7. Schneider JA, Arvanitakis Z, Bang W, Bennett DA. Mixed brain pathologies account for most dementia cases in community-dwelling older persons. Neurology 2007;69: 2197–2204.

8. Kawas CH. The oldest old and The 901 Study. Alzheimers Dement 2008;4:S56–S59.

9. Corrada MM, Berlau DJ, Kawas CH. A population-based clinicopathological study in the oldest-old: The 901 Study. Curr Alzheimer Res 2012;9:709–717.

10. White L, Petrovitch H, Hardman J, et al. Cerebrovascular pathology and dementia in autopsied Honolulu-Asia Aging Study participants. Ann NY Acad Sci 2002;977:9–23.

11. Sonnen JA, Larson EB, Crane PK, et al. Pathological correlates of dementia in a longitudinal, population-based sample of aging. Ann Neurol 2007;62:406–413.

12. Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 1991;82:239–259.

13. Mirra SS, Heyman A, McKeel D, et al. The Consortium to Establish a Registry for Alzheimer’s Disease (CERAD): part II: standardization of the neuropathologic assessment of Alzheimer’s disease. Neurology 1991;41:479–486.

14. Hyman BT, Trojanowski JQ. Consensus recommendations for the postmortem diagnosis of Alzheimer disease from the National Institute on Aging and the Reagan Institute Working Group on diagnostic criteria for the neuropathological assessment of Alzheimer disease. J Neuropathol Exp Neurol 1997;56:1095–1097.

15. Esiri MM, Wilcock GK, Morris JH. Neuropathological assessment of the lesions of significance in vascular  dementia. J Neurol Neurosurg Psychiatry 1997;63:749–753.

16. Leverenz JB, Hamilton R, Tsuang DW, et al. Empiric refinement of the pathologic assessment of Lewy-related pathology in the dementia patient. Brain Pathol 2008;18: 220–224.

17. Amador-Ortiz C, Dickson DW. Neuropathology of hipocampal sclerosis. Handb Clin Neurol 2008;89:569–572.

18. Mackenzie IR, Neumann M, Bigio EH, et al. Nomenclature and nosology for neuropathologic subtypes of frontotemporal lobar degeneration: an update. Acta Neuropathol 2010;119:1–4.

19. Folstein MF, Folstein SE, McHugh PR. “Mini-Mental State”: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189–198.

20. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders: DSM-IV. Washington, DC: American Psychiatric Association; 1994.